as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹5,209.0
Change
+50.0 (0.97%)
Open
₹5,179.0
Prev. Close
₹5,159.0
Day High
₹5,280.0
Day Low
₹5,171.0
Volume Analysis
Traded
1,157
Delivered
212
Delivery %
18.32%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Promoter holding is rising
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹5,378.0 | ₹5,329.0 | ₹5,269.0 | ₹5,220.0 | ₹5,160.0 | ₹5,111.0 | ₹5,051.0 |
| Fibonacci | ₹5,329.0 | ₹5,287.36 | ₹5,261.64 | ₹5,220.0 | ₹5,178.36 | ₹5,152.64 | ₹5,111.0 |
| Camarilla | ₹5,238.98 | ₹5,228.98 | ₹5,218.99 | ₹5,220.0 | ₹5,199.01 | ₹5,189.02 | ₹5,179.03 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
-1.35%
1 Month
-0.7%
3 Months
+2.25%
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Dr. Agarwal's Eye Hosp L holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 66/100. The strongest factor is Corporate Governance (100/100), while Liquidity (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising. FII holding has been rising.
TopFund Score — Fundamentals Quality
66/100 — GoodData confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
AGM on Sep 9 approved Rs4 dividend, audited accounts, director reappointment, and remuneration revisions.
World’s first dedicated Pinhole Pupilloplasty Centre launched in Chennai on August 27, 2026.
Newspaper Advertisement published for the 32nd Annual General Meeting is submitted.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 27.82% | 27.47% | 27.47% | 27.46% | 26.32% | 26.22% | 24.82% | 24.29% | 23.22% | 23.15% | 22.99% | 23.03% |
| Promoters | 71.89% | 71.89% | 71.89% | 71.9% | 71.9% | 71.9% | 71.9% | 71.9% | 72.67% | 72.67% | 72.67% | 72.67% |
| FII | 0.28% | 0.63% | 0.64% | 0.65% | 0.83% | 0.84% | 1.33% | 1.49% | 1.74% | 1.82% | 2.2% | 2.24% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.96% | 1.04% | 1.95% | 2.31% | 2.36% | 2.36% | 2.12% | 2.05% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Dr. Agarwal's Eye Hosp L (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 444,405 | 35.2 | 5.32 | 16.0% |
| Divi S Laboratories Ltd | 255,487 | 85.8 | 15.25 | 16.5% |
| Torrent Pharmaceuticals L | 189,746 | 85.0 | 20.11 | 27.4% |
| Apollo Hospitals Enter. L | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 115,890 | 23.8 | 4.32 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
Which Mutual Funds Hold Dr. Agarwal's Eye Hosp L?
Frequently Asked Questions about Dr. Agarwal's Eye Hosp L
Dr. Agarwal's Eye Hosp L (DRAGARWQ) closed at ₹5,209.0 on NSE on 25 September 2026, up 50.0 (0.97%) from the previous close.
Dr. Agarwal's Eye Hosp L trades on the NSE (National Stock Exchange of India) under the symbol DRAGARWQ.
Dr. Agarwal's Eye Hosp L has a TopFund Quality Score of 66/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Dr. Agarwal's Eye Hosp L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.